Systemic lupus erythematosus in childhood (Q78374010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

review article

1 reference

title

Systemic lupus erythematosus in childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

13 December 2019

main subject

1 reference

inferred from title

author name string

Marisa Klein-Gitelman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

Andreas Reiff

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

Earl D Silverman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

Rheumatic Diseases Clinics of North America

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

561-77, vi-vii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Systemic lupus erythematosus--survival patterns. Experience with 609 patients

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Central nervous system involvement in childhood systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Lupus nephritis in children

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Female sex hormones at the onset of systemic lupus erythematosus affect survival

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Prognostic determinants in lupus nephritis: a long-term clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Lupus nephritis in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Long-term efficacy of azathioprine treatment for proliferative lupus nephritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

The very long-term prognosis and complications of lupus nephritis and its treatment

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Treatment of lupus nephritis in children

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

The diagnosis and management of systemic lupus erythematosus in childhood

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Cerebral vein thrombosis in childhood systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Neuropsychological assessment of children and adolescents with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

The pathogenesis of central nervous system manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Association of IgG Anti-Brain Antibodies with Central Nervous System Dysfunction in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Case series: neuropsychiatric symptoms with pediatric systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Systemic lupus erythematosus in childhood; a clinical study

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

The natural history of systemic lupus erythematosus by prospective analysis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Systemic lupus erythematosus in childhood

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Presence of thyroid abnormalities in children with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Systemic lupus erythematosus associated with acute Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Epstein-Barr virus-associated Kikuchi disease in two children

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Antigen-specific antibody responses in lupus patients following immunization

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Impaired response to pneumococcal vaccine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Influenzal Vaccine Response in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Influenza immunization in systemic lupus eruthematosus. A double-blind trial

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Immunisation of patients with systemic lupus erythematosus: the current state of play

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Vaccination and systemic lupus erythematosus: the bidirectional dilemmas

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Expression of IgM and IgG autoantibodies in pediatric and adult systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Homozygous C2 deficiency with fulminant lupus erythematosus. severe nephritis via the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

Selective IgA Deficiency in Connective-Tissue Diseases

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(02)50015-7

7 January 2021

10.1016/S0889-857X(02)00015-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380370 AND SRC:MED&resulttype=core&format=json

13 December 2019

1 reference